… ProQR Therapeutics to Host Virtual R&D Event on March 29, 2023 LEIDEN, Netherlands & CAMBRIDGE, … (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through …
… ProQR Supports Rare Disease Day 2018 and Honors Henri A. … the legacy of the late Henri A. Termeer, co-founder of ProQR, being held on the same day in Boston, MA. Henri … Genzyme and a visionary and pioneer for rare diseases, was ProQR’s co-founder in 2012 and vice chairman of the …
… ProQR Announces Webcast of Presentation at Upcoming HC … will be accessible from the “Investors & Media” section of ProQR’s website ( www.proqr.com ) under ‘Events’, beginning January 11, 2021. …
… ProQR Announces Webcast Presentation at the 2024 Cantor … (GLOBE NEWSWIRE) -- ProQR Therapeutics NV. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through … will be available from the “Investors & Media” section of ProQR’s website under “Events”. A replay of the webcast will …
… ProQR Announces Closing of Underwritten Public Offering and … (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (“ProQR”), a company dedicated to changing lives through … and commissions and other offering expenses payable by ProQR. All of the shares in the Offering were sold by ProQR. …
… ProQR Announces Conference Call to Discuss the Axiomer® RNA … & CAMBRIDGE, Mass., Sept. 08, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through the …
… ProQR to Host R&D Day in New York on January 29 LEIDEN, Netherlands & CAMBRIDGE, Mass., Jan. 03, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR) will host a Research & … ET at the Lotte New York Palace Hotel in New York, NY. The R&D day will feature presentations by internal ProQR and …
… ProQR to Present at the H.C. Wainwright Global Life Sciences … be accessible from the ‘Investor Relations’ section of ProQR’s website ( www.proqr.com ) under ‘Events and Presentations’. The …
… ProQR Appoints David M. Rodman, MD as Chief Development … the Netherlands, March 27, 2017 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR) today announced that it … of RNA approaches to treating disease.” said Noreen R. Henig, MD, Chief Medical Officer. “There are very few …